Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19250839 | 0.79 | PTPN1 (0.31) | — | |
| SCHEMBL5569903 | 0.79 | CHRM2 (0.38) | CYP1A2 | |
| SCHEMBL17084618 | 0.72 | PTPN2 (0.32) | — | |
| SCHEMBL17084620 | 0.72 | PTPN2 (0.32) | — | |
| SCHEMBL1783831 | 0.71 | PTGS1 (0.36) | CYP1A2UGT2B7 | |
| SCHEMBL4605915 | 0.71 | UGT2B7 (0.34) | EPHX1CYP1A2UGT2B7 | |
| SCHEMBL4606059 | 0.71 | UGT2B7 (0.34) | EPHX1CYP1A2UGT2B7 | |
| SCHEMBL21441575 | 0.71 | UGT2B7 (0.34) | EPHX1CYP1A2UGT2B7 | |
| SCHEMBL4605622 | 0.71 | UGT2B7 (0.34) | EPHX1CYP1A2UGT2B7 | |
| SCHEMBL4608224 | 0.71 | UGT2B7 (0.34) | EPHX1CYP1A2UGT2B7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3122713-B1 | PROCESS FOR THE PRODUCTION OF 1-(5,5-DIMETHYLCYCLOHEX-1-EN-1-YL)ETHANONE AND 1-(5,5-DIMETHYLCYCLOHEX-6-EN-1-YL)ETHANONE | DSM IP ASSETS BV (NL) | 2019-04-24 | — | — | EP | disclosed |
| US-20170217864-A1 | PROCESS OF PRODUCTION OF 1-(5,5-DIMETHYLCYCLOHEX-1-EN-1-YL)ETHANONE AND 1-(5,5-DIMETHYLCYCLOHEX-6-EN-1-YL )ETHANONE | DSM IP ASSETS B.V. (NL) | 2017-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170217864-A1 | PROCESS OF PRODUCTION OF 1-(5,5-DIMETHYLCYCLOHEX-1-EN-1-YL)ETHANONE AND 1-(5,5-DIMETHYLCYCLOHEX-6-EN-1-YL )ETHANONE | EEF2K, CYP2E1, EIF2AK1 | EPHX1 614/4885CYP1A2 141/4885UGT2B7 880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.